AK
Ashish Kumar Singh
About Ashish Kumar Singh
Data last updated:
Ashish Kumar Singh is a Director at Nucleus Laboratories (India) Limted (since 2000). The company operates in Pharma. Nucleus Laboratories (India) Limted reported revenue of ₹2.48 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Nucleus Laboratories (India) Limted U24231UP1999PLC024944 | Director | 27 Nov 2000 | 1999 | ₹2.48 Cr (FY 2020) | Active |
Board colleagues of Ashish Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chandana Shrivastava | 09523772 | Nucleus Laboratories (India) Limted | Director |
| Debashish Saha | 10160104 | Nucleus Laboratories (India) Limted | Director |
| Gyan Prakash Shrivastava | 08545629 | Nucleus Laboratories (India) Limted | Director |
| Himani Shukla | 11219612 | Nucleus Laboratories (India) Limted | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashish Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashish Kumar Singh
Ashish Kumar Singh currently holds 1 directorship: Nucleus Laboratories (India) Limted (Director, since 27 Nov 2000, revenue ₹2.48 Cr (FY 2020)).
Ashish Kumar Singh was first appointed on 27 Nov 2000 as Director at Nucleus Laboratories (India) Limted.
The current boards of Ashish Kumar Singh's companies include Chandana Shrivastava (Nucleus Laboratories (India) Limted), Debashish Saha (Nucleus Laboratories (India) Limted), Gyan Prakash Shrivastava (Nucleus Laboratories (India) Limted), Himani Shukla (Nucleus Laboratories (India) Limted).